Found 27 matching trials
Nivolumab and Yttrium Y 90 Glass Microspheres in Treating Patients With Advanced Liver Cancer
PHASE1The purpose of this study is to identify maximum tolerated dose (MTD), that...
Location
Northwestern University
Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial
PHASE1This phase I/II trial tests the safety, side effects and effectiveness of r...
Location
UCLA / Jonsson Comprehensive Cancer Center
Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia
NAEvaluate the safety and efficacy of Yttrium-90 (90Y) radioembolization for ...
Location
Northwestern University/Northwestern Memorial Hospital
Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors
PHASE1The purpose of this study is to provide supervised access to treatment with...
Location
Cancer Treatment Centers of America at Southwestern Regional Medical Center
Radiolabeled Glass Beads Used for Treating Patients With Primary Liver Cancer When Surgery is Not an Option
NAFewer than 15% of hepatoma patients are suitable candidates for surgical re...
Location
Multiple Locations
Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery
PHASE2RATIONALE: Chemoembolization kills tumor cells by blocking the blood flow t...
Location
Northwestern University, Northwestern Memorial Hospital
Nivolumab and Yttrium-90 in Treating Patients With Liver Cancer Undergoing Surgical Resection
EARLY_PHASE1This early phase I trial studies how well nivolumab and yttrium-90 work in ...
Location
Northwestern University
Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery
EARLY_PHASE1This clinical trial studies radiolabeled glass beads (yttrium Y 90 glass mi...
Location
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
Quality of Life in Patients Undergoing Embolization Using Yttrium Y 90 Glass Microspheres for Primary or Metastatic Liver Cancer
N/ARATIONALE: Learning about quality of life in patients with cancer undergoin...
Location
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Yttrium Y 90 Glass Microspheres in Treating Patients With Unresectable Hepatocellular Carcinoma
NAThis trial studies how well yttrium Y 90 glass microspheres work in treatin...
Location
M D Anderson Cancer Center